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--I Ef;ect of Time to Thrombolyllc Therapy on infarct 
Size Assessed by Tomographlc Sestemibl 
Perfualon Imaging 
Raymond J. Gibbons, Robin S. Roberts, Timothy R Christian, Salim Yusuf 
for the CORE Investigators. Mayo Clinic, McMaster University; Ham#ton, 
Ontario, CANADA 
Previous attempts to demonstrate an association between infarct size (as 
assessed by left ventdcutsr function) and the duration of chest pain prior to 
initiation of thrombolytic therapy have yielded conflicting results. The CORE 
trial is an international randomized dose-renging trial of peloxamer 198 
which randomized 2,954 patients with acute myocardial infarction (< 12 
hours' duration) between 5/4/94 and 6/25/95. A substudy used tomographic 
sastamibi perfusion imaging to assess infarct size in 1,180 patients. Of these 
patients, 1065 received acute thmmbolytie therapy (efreptokinase or t-PA) 
and had analyzable images. Infarct size as a percent of the left ventricle was 
measured using previously established techniques at a central laboratory. 
The time to thrombelytic therapy was significantly (p = 0.014) associated with 
infarct size: 
"lime to'l~rornpolysis n Infarct Size (% LV) 
< 2 hours 309 19.5 ± 18.8 
2-4 hours 396 22.5 4- 20.0 
4-12 hours 360 23.9 4. 20.5 
After adjustment for infarct location, prior infarct, thrombolytio and dose 
of pofoxamer 188, time remained significant (p = 0.027). However, a 2 hr 
increase in time was associated with an increase in infarct size of only 1.1% 
of the LV, compared to an increase of 8.1% for prior infarction and 16.7°/o for 
anterior infarction. 
Conclusion: "rime to initiation of thrombolytic therapy is a significant de- 
terminant of infarct size as assessed by tomographio sealamibi perfusion 
imaging in the CORE trial. The magnitude of its effect is small compared to 
prior infarction or infarct location. 
"5-'1 The Fate of  Patients With Previous Stroke Given a 
Thrombolysis for  Acute Myocardial  Infarction 
Solomon Behar, David Tarme, Hacoch Hod, Valentina Boyko, 
Shmuel Gottlieb. Neufeld Cardiac, Research Institute, Sheba Medical 
Center, Tel Hashomer, Isra~' 
Patients (pts) with a history of stroke (HS) have a relative centraindication 
for thrombolytic therapy (TT) after acute myocardial infarction (AMI). We 
compared the charectedstica and outcome of lots with HS treated or not 
treated with TT among 2010 unselected lots after AMI, hospitalized in 25 
CCUs in Israel. 
HS and "1"1" HS without'IT p 
(n = 29) (n = 87) Value 
Men (%) 76 72 NS 
Age (mean ± s.d). 72 ± 10 yrs 67 ± 10 yrs 0.01 
Diabetes (%) 24 40 NS 
Hypertension (%) 59 63 NS 
Recurrent MI 34 41 NS 
CHF/P.Edema (%) 21 21 NS 
PAF (%) f0 18 NS 
Cardlogenlc shock (%) 14 7 NS 
Stroke (%) 3 2 NS 
Coronary anglography (%) 14 14 NS 
PTCA/CABG (%) 3 10 NS 
30-day mortality (%) 14 23 NS 
The overall incidence of stroke was similar in both groups. No cases of 
Intracranlal hemorrhage were observed am,~ng pts treated with TT. After 
adjustment for age, CHF, diabetes and PAF, the 30-day mortality odds ratio 
for those treated with TT was 0.63 (90%CI 0.18-2.15). This study suggests 
that selected lOtS with HS may benefit from TT. 
['~"6-3--3-3~ Fibrinolytica vs Primary Angiop lasty  in Acute 
Myocardial  Infarction (FAP): A Randomized Trial in 
a Communi ty  Hospital in Argent ina 
Liliana Gdnfald, Daniel Berrocal, Jorge Balardi, Alejandre Spinetta, Carlos 
Rojas Matas, Pablo Oberti, Heman Doval, Oscar B&zzino, Arturo Cagide. 
Hospital Italiano de Buenos Aires, Argentina 
Percutaneous transluminal coronary angioplasty (PTCA) has became an 
altemaltve to thrombelytios as initial approach in the treatment of acute 
myocardial infarction (AMI). The purpose of this study was to determine if 
primary PTCA: 1) was feasible in our media and 2) could improve the clinical 
and angtographio outcome. Patients (p) within 12 hrs of an AMI, eligible for 
thrombolyals, were included. Exclusion criteria ware cardiagenio shock, and 
LBBB. The end points were: 1) 50% reduction of ST elevation in the EKG at 
120 minutes after randomization and 2) presence of TIMI 3 flow in the infarct 
related artery th the a.-.glogram prior to discharge. A composite of In-hospital 
clinical events (death, extension of MI, development of heart failure, stroke 
and major bleeding) was a secondary end point. From 10/93 to 8/95, 112 
p were randomized to streptokinese (SK) 1.5 K U (58 p) or primary PTCA 
(54 n). Baseline clinical and infarct location characteristics were similarly 
distributed in both groups. The mean age was 66 ± 23 years, with 71% 
male gender. The time from the onset of symptoms to randomization was 
242 4- 138 rain for PTCA and 258 4- 162 for SK (p = NS). The anglngraphio 
success for PTCA was 91%. The interval of time from symptoms onset to 
ST 50% decrease was 325 4- 144 rain for PTCA and 334 ± 151 for SK (p 
= NS). Resolution of ST at 120 mln was 79.6% for PTCA and 50% for SK 
(p = 0,002). In hospital mortality was 9,2°/= for PTCA and 10.3% for SK (p = 
NS). Angfographic follow-up was obtained in 83°/,, of the p in a mean of 8 4- 4 
days. TIMI 3 flow was found in 95% for PTCA and 63.6=/,, for SK (p = 0.001). 
The combined end point of major events was 12.9% for PTCA and 25.8% 
for SK (p = NS). Thus event free survival was 87% and 74% respectively. 
Conclusions: 1) In this study primary PTCA was feasible and as save as SK, 
2) PTCA showed a significantly: a) greater resolution in ST changes and b) 
greater incidence of TIMI 3 flow in the infarct related artery prior to discharge 
than SK. 3) In hospital major events showed a tendency to be reduced with 
PTCA. 
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[ '~'~- '1 Non Q-Wave Infarction Post Myocardial 
Thrombolyais. What Are They Really? (How 
Should They Be Classified?) 
Robert Dupuls, Claude Lauzon, Richard F. Davies, Mado Talajic, Duncan 
J. Stewart, Wayne J. Wamica, Martin Gardner, Bruce Sussex, 
Pierre Savard, Etel Mikes, John Ferguson, Jean L. Rouleau. Thetford 
Mines, Quebec, Canada 
Non Q-wave MI (NQ) differ from Q-wave MI (Q) for their natural evolution, 
Thrombolyals (TL) has increased the number of NQ resulting from aborted 
transmural MI. How do they evolve and how should they be classified remains 
unclear. CAMI is a Canadian multicenter study where 4133 consecutive MI 
were prospectively recruited between 1990 and 1992. Transferred patients 
(1007) were excluded and 2368 accepted a complete follow-up. We com- 
pared Q and NQ with or without TL. 
~ariables Q post Q No NQ post NQ No 
TL(1) TL(2) TL(3) 1"1 ~4) 
N (%) 1003 (32) 760 (24) 339 (11) 1024 (33) 
1vs3 3v04 
21 daysdeath* 69(6.9) 115 (15) 24(7.1) 98 (9.6) NS NS 
1 y. death* 105 (11) 162 (21) 38 (11) 182 (18) NS & 
1 y. rec Ml** 60 (7,6) 52 (9.3) 26 (9.6) 67 (9.0) NS NS 
1 y. rec Ang °° 375 (47) 269 (48) 150 (55) 384 (52) # NS 
PTCA (1 y,)** 227 (29) 104 (19) 90 (33) 188 (21) NS & 
CABG (1 y.)** 87 (11) 74 (13) 36 (13) 131 (18) NS NS 
• On total cohort (3126), °, with complete follow-up, #p < 0.05, Sp < 0.01 
All groups showed significant baseline characteristic differences, Previous 
MI, PTCA and CABG conferred a much higher risk to develop a NQ either 
with or without TL TL was the most important prognostic factor and both 
groups post TL (Q or NQ) showed identical outcome (cf Table). 
We conclude that NQ post TL behave like Q pest TL and has a much better 
prognosis than NQ without TL Therefore they should be considered either 
as a special category of MI or together with Q for future studies. 
~ Nonfatal Reinfarction as an Independent 
Riskfactor for Subsequent Mortality in 
Post-Myocardial Infarction Patients 
Ran I". van Domburg, Jaap W. Deckers, Afda J. Azar, Paul RM.M. van 
Bergen, Jan J.C. Janker. University Hospital Dijkzigt and Erasmus 
University Rotterdam, The Netherlands 
The independent risk carded by nonfatal rsinfarction for subsequent death 
has seldom been quantified. The p:'ognostic significance of nonfatal re- 
infarction was determined from the ASPECT trial database. From 1986 
till 1992 3404 pest-myocardial infarction patients were assigned to long- 
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term oral anticoagulant treatment (1700 patients) or placebo (1704 pa- 
l]ants) tn a deubis-bllnd, placebo controlled, multicenter Mel. Mean age 
was 61 years and 80% were males. The trial medicalfon was discontinued 
and after a median follow-up of 3 years (0.5--6 years), 359 patients had 
died. A first reinfercllon was found in 356 patients of which 301 non-fatal 
(within 30 days). Subsequent mertality occurred in 42 patients. A multi- 
vadate Cox propsrUonal harzard model was performed for histery, clini: 
col chamcteri~ce and nonfatal reinfarction as a time dependent predictor 
variable. 
ne mi~,¢een 
m ~  m !  m 
I l l  tN  I I  
m 
HR 95% CI 
Nonfatal mMI 2.03 1,45-2.83 
Age 2.30 1.84-2.88 
Previous Mi 1.54 1.15-2.06 
History of angtn& 1.30 1.01-1.68 
Heartfallum Inhospilal 1.74 1.25-2.42 
Thmmbolyti¢ therapy 0.71 0.51-0.98 
Heaffrate >_ 70bpm 1.68 1.32-2.16 
After adjusting for characteristics, as mentioned above, nonfatal roirffarc- 
tton retained in the model (hazard ratio: 2,03; 1.45-2.83). Thus, nonfatal 
relnfarction carries a strong and independent dsk for subsequent mortality in 
patients surviving an acute myocardial iofapclicn. 
'~ ' ]  Silent Exercise-lndu¢~=d Ischemla in Stable 
Patients One Year Alter Myecardlal Infamtion: 
6-Yearn Fellow-Up, 
Giannl Casalla, Pier Camillo Paveai, Maflaroseria di Nire, Massimo Medda, 
Andrea Rubbeli, Pletro Sangtorglo, Daniale Bra¢cheltL Card/o/ogy Sect/on, 
Ospedale M~giore, Bologna ITALY 
Silent exereise.indu~l ischemia is a common finding after myocardial in- 
larction (AMI), to assess its prognostical relevance in stable patients, we 
evaluated 766 consecutive pte. (mean age: 57.2 -I- 8,6 yrs.; male: 89%) 
who from 5/1988 to 111991 underwent a Bruce Treadmill test at least I year 
after a first Q wave AMI and whose clinical and ET data were prospectively 
entered in our database. A cardiac follow-up (mean length: 51 "4- 20 months) 
was completed (Kaplan.Meyer overall death at 6-yrs: 9.1%) and 3 different 
e,Jbgreups were retrospastively identified according to ET results: Group 
I = 156 pts. with silent exercise ischemia; Group ~- = 75 pts. with symp- 
tomatic exercise Ischemia; Group 3 = 99 pts. with a negative hi'. Baseline 
elinicat vadabfas were similar between the groups. Pts. wllh silent tschemia 
had less functional impalremant and exercise ischemia than symptomatic 
[longer exercise duration (p < 0.001), higher double product (p < 0.001), 
higher ischemic threshold (p < 0.001), shorter time to ST normalisetisn (p < 
0.00t)]. 
Dudng the follow-up overall mortality (p = NS) and reinfaretion (p = hiS) 
were similar In the 3 groups, while event-free probability for unstable angina Co 
0 8 12 la 2¢ 30 N 42 4a .~ ~ m ~2 
< 0.05, fig. 1 ) or PTCA/CABG (p = 0.06) was lower for pts. with symptomatic 
exemise Ischemia. 
Thus, silent exercise ischemia in stable pte. one year after AMI signifies 
ischemla of less severity when compared with symptomatic. Moreover in 
stable post-AMI pte., exercise ischemia, whether symptomatic or not, has 
a low impact on prognosis. Thus, silent exercise ischemia is not useful in 
identifying lOtS. at increased dsk for subsequent coronary events. 
~ ' ~  The Predictive Value o f  LV Systelic Sphericity 
Index, a mgni f icat ion-maependent Assessment ef 
LV Shape 
Gervaslo A. Lamas, Gary Mitchell, Greg C. RaPer, Sidney C. Smith, 
Bernard J. Gemh0 Edward M. Geltman, Eugene Braunwatd, Marc A. Pfelfer, 
for the SAVE Ilwestigafore. Mount Sinai Medical Center and the University 
of Miami School of Medicine, Miami Beach, FL 
We ~ e l y  evaluated the ability of asimple, magnfticalion-indepsndent 
measure of LV shape, systolic spherk~y index (SSI), to predict clinical events 
in 700 SAVE skidy patients who underwent cardiac cathetedzatisn and left 
ventriculogrephy within 16 days of MI. Systolic sphericity index is defined as 
uncorrected ellipsoidal end-systolic LV volume (X100) d'wided by ~ volume 
of a sphere whose diameter is the uncorrected LV long exis. Thus, the SSI of 
a sphere measures 100%. Patients were 57:1:11 years, 83% male, and 64% 
had sustained an anterior infarction. Average radionuclide ejection fraction 
~as 32% ~ 7. ,%SI of MI paliants vras 29% 4- 8 (range 11-76%), which was 
greater than SSI of normals (20% ~ 4). SSI con'elated poorly with end systolic 
volume, R = 0.33, and with EF (R : -0.27). Tercfles of SSI from least to 
most spherical predicted a progressive increase in the occurrence of severe 
heart failure or corcrtovascolar mortality over a 3.5 yearfotiowup (1:16.5%, 
2".24.9%, 3:35.0% p < 0.561 ). Logist~ regression analysis demonstrated that 
hypertension (l~elillcod ratio (LR) 1.61, p < 0.001 ), redionuclide EF (LR 1.09 
for each 1-peint decrement, p < 0.001), number of diseased coronaries (LR 
1.75 for each adddJonel vessel, and SSI (LR 1.04 for each 1 -point increment, 
p = 0.001) were independent predictors of clinical outcome. 
Conclusion: SSI is a descriptor of LV shape which does not require 
magnificatisn-correction. The finding that SSI adds prognostic information 
independent of EF suggests that LV disto,~on imposes additional disadvan- 
tage beyond contrastile dysfunc6no in MI survivors. 
~2"~ Prognost le Indlcaters Mortal ity After an ef  3-Year 
Acute Myoca~llat Infarction 
Kenneth Caidah|. Magnus Edner, Jens Beming, Steen Carstensen, Vernon 
V.S. Bona.,~, Kaj Undvall, Tod~m Omland, Anita Samueisson, Susan 
E. W~son, Dennis W.T. Ngsan. Un/vets/ty Hosp/te~ Gothenburg and 
Stock~lm, Sweden, Copenhagen, Denmark, and ~ Nonv~ 
The value of various prognostic indcalors after an acute myocardial infsm~n 
(AMI) is not astebr~hed. To evaluate the ~ informabon of clinical 
and ~ iograph i¢  indexes among pts subjected to modem therapy, we 
followed 428 consecutive pts within tt,e CONSENSUS II for at least 3 years. 
The baseline investigabon was perktmed 3-5 days after the AMI. Death 
frem any cause was noted in 101 ~S, whereof card~asc~lar death in 88 
10is. Results are based on total mortality. A highly significant (P < 0,001) 
relation to mortality was found for s~olic (LWI-S) and d'~stolic LV volume 
indexes, ejection fraction, global ~zll motion index (WMI), age, heart rate, 
prior AMI, pdar CHF, betebtock~r tmatmant, atrial fibn'ftabon and Klllip class. 
Tabulated variables (mean :1: S.D.) gave independent prognos~c information 
in a stepwtse icgistic ~¢-g~essicn rondel. 
Alive Dead P-value 
WMt (scorn) 1.37±0.3 1.65+0.4 0.0001 
LW1.S (ml/~) 24.5=1=10 35.6:1:18.0 0.0¢!57 
Age (yea~) as.l:l: 10.9 71.0~9.9 C.0279 
Mortality was not related to blood pressure, known hypertension, the 
Doppler FJA ratio, or sex. Thus, e¢'.heca~graphic wall motion and LWI-S 
together with age contain a powec~el set of variables for prognostication of 
outcome dudng the 3 year period after an AML 
~- - - '~  Long-Term e l  Patients With Acute 
Myocardial Infarctilon In the Thrombolys ls  Era 
Dietrich Andrasen, Gerd Stelnbsck ~ ,Thomas Br0ggemann, 
Elks Hoffmann t. Free Unlvetsily of Berlin, Germany; 1University Munich, 
Germany 
The most recent intervention stud'~s L:}n patients with acute myocard~ Infare- 
tion report an In-hospital mollal'dy of 6-8% and a 1-year meltality following 
discha~e of 2-4%. The patients ~ in thase studies were, however, a 
s :  
